Browsing by Author Shapiro, J

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2014Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013Pavlakis, Nick; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos; Price, Timothy; Punt, Cornelis JA; Segelov, Eva; Shapiro, J; Tebbutt, Niall; Northern Clinical School: MedicineCurrent opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013, Expert Review of Anticancer Therapy, vol.14, 12, 2014,pp 1477-1493
2015Does the chemotherapy backbone impact on the efficacy of targeted agents in metastatic colorectal cancer? A systematic review and meta-analysis of the literatureChan, David; Pavlakis, Nick; Karapetis, Christos; Price, Timothy; Segelov, Eva; Shapiro, J; Tebbutt, Niall; Northern Clinical School: Medicine; Northern Clinical School: MedicineDoes the chemotherapy backbone impact on the efficacy of targeted agents in metastatic colorectal cancer? A systematic review and meta-analysis of the literature, PloS One, vol.10, 8, 2015,pp 1-17
2014Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancerSimes, Robert John; et al, Various; Harbison, C; Jonker, Derek J.; Karapetis, Christos (Chris); Langer, C; Malone, DP; O’Callaghan, C; Price, Timothy; Shapiro, J; Tebbutt, Niall; Tu, Dongsheng; School of Public Health: NH&MRC Clinical Trials CentreEpiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer, British Journal of Cancer, vol.110, 3, 2014,pp 648-655
2015EVERSUN: A phase 2 trial of alternating sunitinib and everolimus as first line therapy for advanced renal cell carcinoma.Espinoza, David; Hudson, Amanda; Long, Anne; Martin, Andrew; Pavlakis, Nick; Stockler, Martin; Thompson, John; Yip, Sonia; Azad, A; Davis, I D; Goldstein, David; Harrision, M; Harvie, R; Jovanovic, L; Kannourakis, G; Kichenadasse, G; Lowenthal, Raymond M.; Nelson, C C; Shapiro, J; Steer, C; NH&MRC Clinical Trials Centre; Northern Clinical School: Kolling Institute; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; Central Clinical School: Surgery; NH&MRC Clinical Trials CentreEVERSUN: A phase 2 trial of alternating sunitinib and everolimus as first line therapy for advanced renal cell carcinoma., Annals of Oncology, vol.26, 6, 2015,pp 1118-1123
2014The role of biological therapy in metastatic colorectal cancer after first-line treatment: a meta-analysis of randomised trialsPavlakis, Nick; Chan, D; Karapetis, Christos; Price, Timothy; Segelov, Eva; Shapiro, J; Tebbutt, Niall C; Northern Clinical School: MedicineThe role of biological therapy in metastatic colorectal cancer after first-line treatment: a meta-analysis of randomised trials, British Journal of Cancer, vol.111, 6, 2014,pp 1122-1131